The main aim of stock picking is to find the market-beating stocks. But the main game is to find enough winners to ...

As Ethereum (ETH) eyes a potential climb toward $5,000, large sell walls and profit-taking by whales could slow its momentum, ...

As Ethereum (ETH) continues to dominate the smart contract market, seasoned investors are increasingly looking for the next ...

Third, ATM programs, which we've already discussed. The reflexive loop is clear: hype the narrative, stock trades above NAV, ...

Ethereum could flip Bitcoin in market dominance, similar to how equities overtook gold post-1971, according to BitMEX’s Tom ...

SOL has been experiencing some pressure in the recent past, oscillating around critical support levels and failing to regain ...

The UK is modernising its financial markets, with the FCA proposing to let asset managers 'tokenise' investment funds on ...

Overview: BitMine accumulated over 104,000 ETH worth $417 million amid price weakness, reinforcing its long-term bullish outlook.Square enables Bitcoin payments ...

Propanc Biopharma, Inc. is developing a novel therapeutic approach aimed at preventing the recurrence and metastasis of solid tumors by leveraging the anti-cancer potential of pancreatic proenzymes.

Shares in Ethereum treasury firm ETHZilla fell more than 5% after the company announced a 1-for-10 reverse stock split.